| Allergic rhinitis and its impact on asthma J Bousquet, P Van Cauwenberge, N Khaltaev Journal of allergy and clinical immunology 108 (5), S147-S334, 2001 | 5472 | 2001 |
| The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update T Zuberbier, W Aberer, R Asero, C Bindslev‐Jensen, Z Brzoza, ... Allergy 69 (7), 868-887, 2014 | 3474* | 2014 |
| Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria T Maurer, M., Rosén, K., Hsie, H. J., Saini, S New Engl. J. Med., 2013 | 1169 | 2013 |
| EAACI/GA˛LEN/EDF/WAO guideline: management of urticaria T Zuberbier, R Asero, C Bindslev‐Jensen, G Walter Canonica, MK Church, ... Allergy 64 (10), 1427-1443, 2009 | 1072* | 2009 |
| Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report M Maurer, K Weller, C Bindslev‐Jensen, A Giménez‐Arnau, PJ Bousquet, ... Allergy 66 (3), 317-330, 2011 | 985 | 2011 |
| The international WAO/EAACI guideline for the management of hereditary angioedema–the 2017 revision and update M Maurer, M Magerl, I Ansotegui, E Aygören-Pürsün, S Betschel, K Bork, ... World Allergy Organization Journal 11, 1-20, 2018 | 869* | 2018 |
| Macrophage inflammatory protein-1 E Maurer, M., and von Stebuth Int. J. Biochem. Cell. Biol. 36, 1882-1886, 2004 | 865 | 2004 |
| Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs J Bousquet, HJ Schünemann, B Samolinski, P Demoly, ... Journal of Allergy and Clinical Immunology 130 (5), 1049-1062, 2012 | 808 | 2012 |
| EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria T Zuberbier, R Asero, C Bindslev‐Jensen, G Walter Canonica, MK Church, ... Allergy 64 (10), 1417-1426, 2009 | 775 | 2009 |
| Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy A Kaplan, D Ledford, M Ashby, J Canvin, JL Zazzali, E Conner, J Veith, ... Journal of Allergy and Clinical Immunology 132 (1), 101-109, 2013 | 639 | 2013 |
| Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema WT Cicardi, M., Banerji, A., Bracho, F., Malbrán, A New Engl. J. Med. 363, 532-541, 2010 | 637 | 2010 |
| A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis B Paus, R., Müller-Röver, S., Van Der Veen, C Journal of Investigative Dermatology 113, 523-532, 1999 | 626 | 1999 |
| The international EAACI/GA˛LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria T Zuberbier, AH Abdul Latiff, M Abuzakouk, S Aquilina, R Asero, D Baker, ... Allergy 77 (3), 734-766, 2022 | 616 | 2022 |
| Risk of first‐generation H1‐antihistamines: a GA2LEN position paper MK Church, M Maurer, FER Simons, C Bindslev‐Jensen, ... Allergy 65 (4), 459-466, 2010 | 587 | 2010 |
| Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study SS Saini, C Bindslev-Jensen, M Maurer, JJ Grob, EB Baskan, MS Bradley, ... Journal of Investigative Dermatology 135 (1), 67-75, 2015 | 511 | 2015 |
| Mast cells as sentinels in innate immunity CS Galli, S. J., Maurer, M., and Lantz Curr. Opin. Immunol., 53-59, 1999 | 500 | 1999 |
| A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria S Saini, KE Rosen, HJ Hsieh, DA Wong, E Conner, A Kaplan, S Spector, ... Journal of Allergy and Clinical Immunology 128 (3), 567-573. e1, 2011 | 495 | 2011 |
| How to assess disease activity in patients with chronic urticaria? A Młynek, A Zalewska‐Janowska, P Martus, P Staubach, T Zuberbier, ... Allergy 63 (6), 777-780, 2008 | 471 | 2008 |
| Epidemiology of urticaria: a representative cross‐sectional population survey T Zuberbier, M Balke, M Worm, G Edenharter, M Maurer Clinical and experimental dermatology 35 (8), 869-873, 2010 | 456 | 2010 |
| Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase M Maurer, S Altrichter, T Bieber, T Biedermann, M Bräutigam, S Seyfried, ... Journal of Allergy and Clinical Immunology 128 (1), 202-209. e5, 2011 | 446 | 2011 |
Martin MetzCharité - Universitätsmedizin BerlinVerified email at charite.de
